Apogee Therapeutics (APGE) Insider Trading & Ownership $52.95 -0.39 (-0.73%) (As of 09/19/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Apogee Therapeutics (NASDAQ:APGE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage36.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$5.22 M Get APGE Insider Trade Alerts Want to know when executives and insiders are buying or selling Apogee Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address APGE Insider Buying and Selling by Quarter Ad Behind the MarketsEx-Wall Street CEO reveals “Millionaire-Maker” SuperdrugScience Magazine called it the "breakthrough of the year"... With projections of 8,966% growth in the next four years.Click here for our #1 "Retirement Window" Stock >>> Apogee Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/4/2024Carl DambkowskiInsiderSell6,665$47.56$316,987.40 9/4/2024Michael Thomas HendersonCEOSell40,000$47.62$1,904,800.00 8/23/2024Jane HendersonCFOSell6,000$48.26$289,560.00 8/7/2024Carl DambkowskiInsiderSell7,335$40.67$298,314.45 8/7/2024Michael Thomas HendersonCEOSell40,000$40.62$1,624,800.00 7/5/2024Michael Thomas HendersonCEOSell15,000$37.26$558,900.00 7/3/2024Carl DambkowskiInsiderSell5,995$37.60$225,412.00 (Data available from 1/1/2013 forward) APGE Insider Trading Activity - Frequently Asked Questions Who is on Apogee Therapeutics's Insider Roster? The list of insiders at Apogee Therapeutics includes Carl Dambkowski, Jane Henderson, Michael Thomas Henderson, and Nimish P Shah. Learn more on insiders at APGE. What percentage of Apogee Therapeutics stock is owned by insiders? 36.10% of Apogee Therapeutics stock is owned by insiders. Learn more on APGE's insider holdings. Which Apogee Therapeutics insiders have been buying company stock? The following insider purchased APGE shares in the last 24 months: Nimish P Shah ($29,750,000.00). How much insider buying is happening at Apogee Therapeutics? Insiders have purchased a total of 1,750,000 APGE shares in the last 24 months for a total of $29,750,000.00 bought. Which Apogee Therapeutics insiders have been selling company stock? The following insiders have sold APGE shares in the last 24 months: Carl Dambkowski ($840,713.85), Jane Henderson ($289,560.00), and Michael Thomas Henderson ($4,088,500.00). How much insider selling is happening at Apogee Therapeutics? Insiders have sold a total of 120,995 Apogee Therapeutics shares in the last 24 months for a total of $5,218,773.85 sold. More Insider Trading Tools from MarketBeat Related Companies: ITCI Insider Trading LNTH Insider Trading ELAN Insider Trading RVMD Insider Trading VKTX Insider Trading CYTK Insider Trading KRYS Insider Trading NUVL Insider Trading BPMC Insider Trading OGN Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: This Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock This page (NASDAQ:APGE) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersAct by Friday, August 16th, to collect this 22% dividendLet's do a little math here... To double your money at a 3% rate of return, you would need around 23 years....Investors Alley | SponsoredWhy You Should NOT Trade This MarketYou'll be interested in our 5-Day Options Trading Challenge, starting September 23. So, what makes this dif...InvestorPlace | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apogee Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apogee Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.